Cómo citar
Extremely low prevalence of asymptomatic COVID-19 among healthcare workers caring for COVID-19 patients in Israeli hospitals: a cross-sectional study
Publicado: 17-07-2025
Elizabeth Temkin
Resumen
Objectives: We aimed to compare the prevalence of asymptomatic coronavirus disease 19 (COVID-19) among clinical staff in designated COVID-19 units versus that among staff in similar units with no known or suspected COVID-19 patients.
Methods: We conducted a cross-sectional survey of healthcare workers (HCWs) in eight Israeli general hospitals. The survey involved a questionnaire and a PCR test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We surveyed HCWs in COVID-19 units and comparison units (internal medicine and cardiology) between 30th April and 7th May 2020.
Results: There were 522 participants: 291 from COVID-19 units and 231 from comparison units. Only one participant (0.2%, 95%CI: 0.005e1.1%)dan asymptomatic nurse on a COVID-19 unitdtested positive for SARS-CoV-2. In participating COVID-19 units there were two symptomatic HCWs with confirmed COVID- 19 in the 2 weeks before the survey; both were infected by contact with a co-worker outside of the COVID-19 unit.
Conclusions: The low prevalence of asymptomatic COVID-19 among HCWs, coupled with an absence of symptomatic COVID-19 acquired during patient care, suggest that Israel's national guidelines for personal protective equipment, which are consistent with those of the World Health Organization, adequately protect HCWs. Elizabeth Temkin, Clin Microbiol Infect 2021;27:130.e1e130.e4 © 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Downloads
Detalles del artículo
Artículos similares
- Carey Kriz, Naiyer Imam , Sarah Zaidi , Breaking Down COVID-19 , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
- Jasmina Mallet, Caroline Dubertret , Yann Le Strat, Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
- Judith Toro Merlo, Edición especial COVID-19 , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
- Anna K. Szkaradkiewicz-Karpi´nska, Andrzej Szkaradkiewicz, Towards a more effective strategy for COVID‑19 prevention (Review) , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
- Marı´a A. Amesty , Jorge L. Alio´ del Barrio, Jorge L. Alio, COVID-19 Disease and Ophthalmology: An Update , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
- Tarik Asselah, David Durantel, Eric Pasmant, George Lau, Raymond F. Schinazi, COVID-19: Discovery, diagnostics and drug development , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
- Ahmed Goha, Kenechukwu Mezue, Paul Edwards, Felix Nunura, Dainia Baugh, Ernest Madu, COVID-19 and the heart: An update for clinicians , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
- José A. Suárez, Laura Naranjo Lara, Julio Castro Méndez, Jaime Torres, Edgar Escalona, Guía para el manejo y control del Síndrome Respiratorio Agudo Severo , VITAE Academia Biomédica Digital: Vol. 3 Núm. 16: Julio-Septiembre 2003
- Laura Naranjo Lara, José Antonio Suárez, Julio Simón Castro Méndez, Jaime Torres, Edgar Escalona, Guía para el manejo y control del Síndrome Respiratorio Agudo Severo , VITAE Academia Biomédica Digital: Vol. 2 Núm. 15: Abril-Junio 2003
- COVID-19 and diabetes. Possible role of polymorphism and rise of telemedicine , VITAE Academia Biomédica Digital: Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
También puede Iniciar una búsqueda de similitud avanzada para este artículo.

